J Cell Mol Med, 2018 · DOI: 10.1111/jcmm.13566 · Published: May 1, 2018
This study investigates the effects of Fibroblast Growth Factor 1 (FGF1) on spinal cord injury (SCI) recovery. FGF1 has shown promise in protecting and regenerating neurons after SCI, but its use is limited by its instability and inability to cross the blood-spinal cord barrier. The researchers used an adeno-associated virus (AAV) to deliver FGF1 to the spinal cord after injury. They found that this method reduced tissue loss, protected neurons, improved tissue recovery, and promoted axon regeneration and remyelination. The study suggests that FGF1 improves functional recovery after SCI by inducing the expression of PRDX1, an antioxidant protein. This, in turn, increases autophagy (a cellular cleaning process) and reduces reactive oxygen species (ROS), which contribute to secondary injury after SCI.
PRDX1 could be a therapeutic target for SCI.
AAV vector is an effective delivery strategy for FGF1.
The findings may provide insights into the clinical application of FGF1 for acute and chronic SCI patients.